Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance

<p>Abstract</p> <p>Background</p> <p>Preventing the emergence of anti-malarial drug resistance is critical for the success of current malaria elimination efforts. Prevention strategies have focused predominantly on qualitative factors, such as choice of drugs, use of co...

Full description

Bibliographic Details
Main Authors:	Lee Sue J, Stepniewska Kasia, Aguas Ricardo, Saralamba Sompob, Maude Richard J, Pongtavornpinyo Wirichada, White Nicholas J, Dondorp Arjen M, White Lisa J, Day Nicholas PJ
Format:	Article
Language:	English
Published:	BMC 2009-11-01
Series:	Malaria Journal
Online Access:	http://www.malariajournal.com/content/8/1/253

Similar Items

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
by: Dondorp Arjen M, et al.
Published: (2008-11-01)

The role of simple mathematical models in malaria elimination strategy design
by: Van Effelterre Thierry, et al.
Published: (2009-09-01)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
by: Day Nicholas PJ, et al.
Published: (2009-02-01)

Risk factors for <it>Plasmodium falciparum </it>hyperparasitaemia in malarious children
by: Happi Christian T, et al.
Published: (2011-10-01)

Modelling malaria elimination on the internet
by: White Nicholas J, et al.
Published: (2011-07-01)

Determinants of MDA impact and designing MDAs towards malaria elimination
by: Bo Gao, et al.
Published: (2020-04-01)

Plasmodium falciparum hyperparasitaemia in children
by: Sowunmi A., et al.
Published: (2004-09-01)

Modulating effects of plasma containing anti-malarial antibodies on <it>in vitro </it>anti-malarial drug susceptibility in <it>Plasmodium falciparum</it>
by: Udomsangpetch Rachanee, et al.
Published: (2010-11-01)

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
by: Stepniewska Kasia, et al.
Published: (2006-12-01)

The role of anti-malarial drugs in eliminating malaria
by: White Nicholas J
Published: (2008-12-01)

Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC<sub>50 </sub>values using a Bayesian approach
by: Brockman Alan, et al.
Published: (2007-01-01)

Hyperparasitaemia during bouts of malaria in French Guiana
by: Carme Bernard, et al.
Published: (2013-01-01)

Anti‐malarial drug effects on parasite dynamics in vivax malaria
by: Nicholas J. White
Published: (2021-03-01)

Computational analysis of binding between malarial dihydrofolate reductases and anti-folates
by: White Nicholas J, et al.
Published: (2010-03-01)

Hyperparasitaemia and phagocytosis of Plasmodium falciparum in fatal cerebral malaria
by: Akshaya Kumar Mohanty, et al.
Published: (2016-01-01)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
by: Nicholas J. White
Published: (2019-10-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
by: Timothy Kinyanjui, et al.
Published: (2020-04-01)

Molekulárně-dynamické simulace komplexů HIV reverzní transkriptázy a jejích potenciálních inhibitorů
by: Saralamba, Sompob
Published: (2006)

Mathematical modelling of antimalarial drug resistance
by: Pongtavornpinyo, Wirichada
Published: (2006)

Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
by: Kanokpich Puaprasert, et al.
Published: (2018-11-01)

Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2.
by: Arjen M Dondorp, et al.
Published: (2005-08-01)

Correction: Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2.
by: Arjen M Dondorp, et al.
Published: (2005-10-01)

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia
by: Rolling Thierry, et al.
Published: (2012-05-01)

Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator
by: Flegg Jennifer A, et al.
Published: (2011-11-01)

Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria
by: James A Watson, et al.
Published: (2019-01-01)

Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri.
by: Naowarat Saralamba, et al.
Published: (2019-01-01)

Authors' Reply: Response to Ian Clark.
by: Arjen Dondorp, et al.
Published: (2006-01-01)

Letter to the editor RE: Reuling et al., 2018 ‘liver injury in uncomplicated malaria is an overlooked phenomenon: An observational study’
by: Arjen M. Dondorp, et al.
Published: (2021-06-01)

Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges
by: Prabin Dahal, et al.
Published: (2017-10-01)

Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application.
by: Sai Thein Than Tun, et al.
Published: (2017-01-01)

Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.
by: Yoel Lubell, et al.
Published: (2014-08-01)

Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos)
by: Bipin Adhikari, et al.
Published: (2018-01-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
by: Woodrow Charles J, et al.
Published: (2010-04-01)

Towards optimal design of anti-malarial pharmacokinetic studies
by: White Nicholas J, et al.
Published: (2009-08-01)

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
by: Richard J Maude, et al.
Published: (2012-01-01)

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias
by: Naowarat Saralamba, et al.
Published: (2018-07-01)

Defining disease heterogeneity to guide the empirical treatment of febrile illness in resource poor settings.
by: Lisa J White, et al.
Published: (2012-01-01)

Hyperparasitaemia during clinical malaria episodes in infants aged 0–24 months and its association with in utero exposure to Plasmodium falciparum
by: Boniphace Sylvester, et al.
Published: (2018-04-01)

Retinopathy and microcirculation in adult severe malaria
by: Hoque Gofranul M, et al.
Published: (2010-10-01)

A review of mixed malaria species infections in anopheline mosquitoes
by: Day Nicholas PJ, et al.
Published: (2011-08-01)